Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI Safety of Otenaproxesul vs Naproxen in Healthy Subjects
NCT03291418Phase 2Completed
- Sponsor
- Antibe Therapeutics Inc.
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of otenaproxesul in osteoarthritis (OA), sponsored by Antibe Therapeutics Inc.. Started Sep 2017; status: completed.
02
Drugs
otenaproxesul
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03291418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291418.